Publication date: September 2026 Source: Clinical Infection in Practice, Volume 32, Supplement Author(s): Michael Backhurst-Braye, David Garner, Colonel Emma Hutley
Acute rheumatic fever with rheumatic heart disease despite appropriately treated invasive Group A Streptococcal infection. // Clinical Infection in Practice. – URL: https://www.sciencedirect.com/science/article/pii/S2590170226001159?dgcid=rss_sd_all
Acute rheumatic fever with rheumatic heart disease despite appropriately treated invasive Group A Streptococcal infection. Clinical Infection in Practice. https://www.sciencedirect.com/science/article/pii/S2590170226001159?dgcid=rss_sd_all
“Acute rheumatic fever with rheumatic heart disease despite appropriately treated invasive Group A Streptococcal infection.” Clinical Infection in Practice.
@article{article116597,
title = {Acute rheumatic fever with rheumatic heart disease despite appropriately treated invasive Group A Streptococcal infection},
journal = {Clinical Infection in Practice},
url = {https://www.sciencedirect.com/science/article/pii/S2590170226001159?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...